Literature DB >> 24937968

Follicular and estradiol parameters that improve success with natural cycle in vitro fertilization.

Michael DiMattina, John David Gordon, Awie Botes, Gerald Celia, Mark Payson, Jennifer Graves-Herring.   

Abstract

OBJECTIVE: To describe clinical thresholds for follicle size and estradiol levels to optimize success with natural cycle in vitro fertilization (NCIVF). STUDY
DESIGN: Descriptive cohort of candidates for stimulated IVF, < 43 years old, with regular menstrual cycles, regardless of ovarian reserve or fertility treatment history. Patients underwent NCIVF, defined as oocyte retrieval, fertilization and embryo transfer after human chorionic gonadotropin (hCG) trigger without luteinizing hormone (LH) suppression or ovarian stimulation medications.
RESULTS: A total of 422 patients underwent 821 NCIVF cycles. Clinical pregnancy rates per cycle start, retrieval, and transfer were 13%, 17%, and 32%, respectively, for all patients and 19%, 25%, and 49% for patients < 30 years old. The threshold estradiol level on day of hCG was 101 pg/mL; below that level no clinical pregnancies occurred. Likewise, a mean follicular diameter > 15 mm was the optimal threshold for hCG trigger. Anti-Müllerian hormone and follicle-stimulating hormone levels did not predict success in NCIVF, and no statistical difference in clinical pregnancy rates between day 3 or day 5 embryo transfer was observed.
CONCLUSION: NCIVF is an effective therapy for infertile patients regardless of their ovarian reserve. Cycle cancellation due to a premature LH surge can be reduced, without sacrificing success, by triggering smaller follicles above a threshold level of estradiol.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24937968

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  6 in total

1.  Natural cycle IVF reduces the risk of low birthweight infants compared with conventional stimulated IVF.

Authors:  Winifred Mak; Laxmi A Kondapalli; Gerard Celia; John Gordon; Michael DiMattina; Mark Payson
Journal:  Hum Reprod       Date:  2016-02-22       Impact factor: 6.918

2.  Optimal Timing of Ovulation Triggering to Achieve Highest Success Rates in Natural Cycles-An Analysis Based on Follicle Size and Oestradiol Concentration in Natural Cycle IVF.

Authors:  Anja Helmer; Isotta Magaton; Odile Stalder; Petra Stute; Daniel Surbek; Michael von Wolff
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-26       Impact factor: 6.055

3.  Development of a predictive model for luteal phase oocyte retrieval in poor responders undergoing natural cycle IVF.

Authors:  Mara Simopoulou; Dionysios Galatis; Evangelos Maziotis; Agni Pantou; Polina Giannelou; Sokratis Grigoriadis; Panagiotis Tzonis; Theodora Griva; Athanasios Zikopoulos; Anastasios Philippou; Michael Koutsilieris; Konstantinos Pantos; Konstantinos Sfakianoudis
Journal:  Sci Rep       Date:  2022-05-11       Impact factor: 4.996

4.  Decrease in preovulatory serum estradiol is a valuable marker for predicting premature ovulation in natural/unstimulated in vitro fertilization cycle.

Authors:  Xuefeng Lu; Shuzin Khor; Qianqian Zhu; Lihua Sun; Yun Wang; Qiuju Chen; Ling Wu; Yonglun Fu; Hui Tian; Qifeng Lyu; Renfei Cai; Yanping Kuang
Journal:  J Ovarian Res       Date:  2018-11-21       Impact factor: 4.234

5.  The greater incidence of small-for-gestational-age newborns after gonadotropin-stimulated in vitro fertilization with a supraphysiological estradiol level on ovulation trigger day.

Authors:  Alexandra S Kohl Schwartz; Vera R Mitter; Sofia Amylidi-Mohr; Pascale Fasel; Mirja A Minger; Costanzo Limoni; Marcel Zwahlen; Michael von Wolff
Journal:  Acta Obstet Gynecol Scand       Date:  2019-08-11       Impact factor: 3.636

6.  The association of serum estradiol level with outcomes of clomiphene citrate/human menopausal gonadotropin ovarian stimulation for in vitro fertilization and embryo transfer.

Authors:  Xiao-Jin Zhang; Su-Ying Liu; Wei Fu; Xiao-Xi Sun
Journal:  Reprod Biol Endocrinol       Date:  2015-10-06       Impact factor: 5.211

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.